Newborn Screening for Fabry Disease: Current Status of Knowledge
Fabry disease is an X-linked progressive lysosomal disorder, due to α-galactosidase A deficiency. Patients with a classic phenotype usually present in childhood as a multisystemic disease. Patients presenting with the later onset subtypes have cardiac, renal and neurological involvements in adulthoo...
Main Authors: | Vincenza Gragnaniello, Alessandro P. Burlina, Anna Commone, Daniela Gueraldi, Andrea Puma, Elena Porcù, Maria Stornaiuolo, Chiara Cazzorla, Alberto B. Burlina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/9/2/31 |
Similar Items
-
Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
by: Vincenza Gragnaniello, et al.
Published: (2021-06-01) -
Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy
by: Vincenza Gragnaniello, et al.
Published: (2023-12-01) -
Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
by: Vincenza Gragnaniello, et al.
Published: (2020-11-01) -
Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy
by: Alberto B. Burlina, et al.
Published: (2019-06-01) -
Newborn screening for Pompe disease in Italy: Long-term results and future challenges
by: Vincenza Gragnaniello, et al.
Published: (2022-12-01)